Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Regulation of lung progenitor plasticity and repair by fatty acid oxidation
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
View: Text | PDF
Research Article Metabolism Pulmonology

Regulation of lung progenitor plasticity and repair by fatty acid oxidation

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is an age-related interstitial lung disease, characterized by inadequate alveolar regeneration and ectopic bronchiolization. While some molecular pathways regulating lung progenitor cells have been described, the role of metabolic pathways in alveolar regeneration is poorly understood. We report that expression of fatty acid oxidation (FAO) genes is significantly diminished in alveolar epithelial cells of IPF lungs by single-cell RNA sequencing and tissue staining. Genetic and pharmacological inhibition in AT2 cells of carnitine palmitoyltransferase 1a (CPT1a), the rate-limiting enzyme of FAO, promoted mitochondrial dysfunction and acquisition of aberrant intermediate states expressing basaloid, and airway secretory cell markers SCGB1A1 and SCGB3A2. Furthermore, mice with deficiency of CPT1a in AT2 cells show enhanced susceptibility to developing lung fibrosis with an accumulation of epithelial cells expressing markers of intermediate cells, airway secretory cells, and senescence. We found that deficiency of CPT1a causes a decrease in SMAD7 protein levels and TGF-β signaling pathway activation. These findings suggest that the mitochondrial FAO metabolic pathway contributes to the regulation of lung progenitor cell repair responses and deficiency of FAO contributes to aberrant lung repair and the development of lung fibrosis.

Authors

Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora

×

Figure 7

Cpt1a deficiency induces mitochondrial dysfunction.

Options: View larger image (or click on image) Download as PowerPoint

Cpt1a deficiency induces mitochondrial dysfunction.
(A) Representative ...
(A) Representative immunoblot showing efficient knockdown (KD) of Cpt1a in MLE 12 epithelial cells. (B) Oleate oxidation rate in Cpt1a-KD, scramble control, and parental MLE 12 cells (n = 3) in the presence and absence of CPT1a inhibitor etomoxir (MLE 12-PBS, n = 3; Scramble-PBS, n = 2; Cpt1a KD-PBS, n = 3; MLE12-PBS, n = 3; Scramble-PBS, n = 3; Cpt1a KD-PBS, n = 2). Data represent mean ± SD; statistical significance was determined by 2-way ANOVA followed by Tukey’s multiple-comparison test. (C) Representative images of BODIPY (lipid) staining of MLE 12 cells. Scale bars: 20 µm (D) Assessment of mitochondrial complex I activity in Cpt1a-KD compared with scramble MLE 12 cells (n = 3, per condition). Data represent mean ± SD; statistical significance was determined by Mann-Whitney U test. (E) NAD+/NADH ratio in Cpt1a-KD and scramble MLE 12 cells (n = 4, per condition). Data represent mean ± SD; statistical significance was determined by 2-tailed, unpaired Student’s t test. (F) Gene expression of senescence marker Cdkn1a in Cpt1a-KD and scramble (n = 4, per condition). Data represent mean ± SD; statistical significance was determined by Mann-Whitney U test. (G) mRNA levels of SASP genes (Gdf15 and Il6) in scramble controls and Cpt1a-KD cells (n = 3, per condition). Data represent mean ± SD; statistical significance was determined by unpaired Student’s t test. (H) Enriched pathways analysis of differentially expressed genes in Cpt1a-KD versus scramble cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts